PDB Short entry for 2K9U HEADER STRUCTURAL PROTEIN 24-OCT-08 2K9U TITLE SOLUTION NMR STRUCTURE OF THE FILAMIN-MIGFILIN COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: GAMMA FILAMIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 919-1032; COMPND 5 SYNONYM: FILAMIN-C, FILAMIN-2, PROTEIN FLNC, ACTIN-BINDING-LIKE COMPND 6 PROTEIN, ABP-L, ABP-280-LIKE PROTEIN; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: FILAMIN-BINDING LIM PROTEIN 1; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: UNP RESIDUES 1-24; COMPND 12 SYNONYM: FBLP-1, MITOGEN-INDUCIBLE 2-INTERACTING PROTEIN, MIG2- COMPND 13 INTERACTING PROTEIN, MIGFILIN; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PGEX5X-1; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 OTHER_DETAILS: SYNTHETIC PEPTIDE OF THE SEQUENCE CORRESPONDING TO SOURCE 12 RESIDUES 1-24 OF HUMAN FILAMIN-BINDING LIM PROTEIN 1, UNIPROT ENTRY SOURCE 13 Q8WUP2, FBLI1_HUMAN KEYWDS CYTOSKELETAL COMPLEX, CELL ADHESION, CELL JUNCTION, CELL SHAPE, KEYWDS 2 CYTOSKELETON, LIM DOMAIN, METAL-BINDING, STRUCTURAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR S.N.ITHYCHANDA,J.QIN REVDAT 2 03-SEP-14 2K9U 1 JRNL VERSN REVDAT 1 23-DEC-08 2K9U 0 JRNL AUTH S.S.ITHYCHANDA,M.DAS,Y.Q.MA,K.DING,X.WANG,S.GUPTA,C.WU, JRNL AUTH 2 E.F.PLOW,J.QIN JRNL TITL MIGFILIN, A MOLECULAR SWITCH IN REGULATION OF INTEGRIN JRNL TITL 2 ACTIVATION. JRNL REF J.BIOL.CHEM. V. 284 4713 2009 JRNL REFN ISSN 0021-9258 JRNL PMID 19074766 JRNL DOI 10.1074/JBC.M807719200 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. THE REGIONS 1-15 AND 109-119 OF REMARK 3 ENTITY 1 (CHAIN A), BECAUSE THEY ARE NOT PART OF IG REMARK 3 (IMMUNOGLOBULIN-LIKE) DOMAIN, HAVE FEW CONTRAINTS AND ARE REMARK 3 ESSENTIALLY UNFOLDED. 2. IN ENTITY 2 (CHAIN B PEPTIDE), THE REMARK 3 REGIONS 1-6 AND 18-24 DO NOT HAVE MANY CONSTRAINTS AND SEEM REMARK 3 UNFOLDED. REMARK 4 REMARK 4 2K9U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-OCT-08. REMARK 100 THE RCSB ID CODE IS RCSB100857. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 302 REMARK 210 PH : 6.4 REMARK 210 IONIC STRENGTH : 0.025 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.1-1 MM [U-100% 13C; U-100% REMARK 210 15N] ENTITY_1, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D HNCACB REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 30 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLY A 11 H LEU A 13 1.50 REMARK 500 O ALA A 64 H SER A 76 1.57 REMARK 500 O LEU A 13 H GLU A 15 1.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ILE A 2 50.63 -172.18 REMARK 500 1 PRO A 3 -82.22 -58.13 REMARK 500 1 GLU A 4 -3.83 66.68 REMARK 500 1 PHE A 6 -152.13 46.16 REMARK 500 1 GLN A 7 -8.90 82.99 REMARK 500 1 PHE A 8 -39.00 -146.98 REMARK 500 1 PRO A 12 40.57 -66.35 REMARK 500 1 LEU A 13 37.39 28.65 REMARK 500 1 GLU A 15 -9.31 62.99 REMARK 500 1 ALA A 18 -15.87 -45.93 REMARK 500 1 GLU A 29 -37.66 -136.81 REMARK 500 1 THR A 43 -130.35 -154.31 REMARK 500 1 ARG A 44 73.98 54.18 REMARK 500 1 GLU A 45 -60.86 -165.14 REMARK 500 1 PRO A 82 162.19 -36.86 REMARK 500 1 ASN A 92 38.71 70.15 REMARK 500 1 ASP A 93 12.79 82.78 REMARK 500 1 LEU A 108 9.30 54.62 REMARK 500 1 ASP A 110 11.12 55.04 REMARK 500 1 ASP A 111 -30.53 -168.28 REMARK 500 1 ALA A 112 75.24 49.25 REMARK 500 1 THR A 116 -80.01 -91.48 REMARK 500 1 THR A 118 58.22 36.60 REMARK 500 1 ALA B 2 90.41 50.97 REMARK 500 1 SER B 3 107.66 -53.31 REMARK 500 1 LYS B 7 -165.43 48.64 REMARK 500 1 ARG B 8 -163.28 -101.53 REMARK 500 1 PHE B 14 -170.35 -177.99 REMARK 500 1 PRO B 20 -173.57 -54.11 REMARK 500 1 ASP B 23 12.70 -160.93 REMARK 500 2 ILE A 2 50.28 -172.27 REMARK 500 2 PRO A 3 -82.71 -57.94 REMARK 500 2 GLU A 4 -18.76 74.11 REMARK 500 2 PHE A 6 -152.49 46.17 REMARK 500 2 GLN A 7 -8.12 83.60 REMARK 500 2 PHE A 8 -39.42 -148.34 REMARK 500 2 PRO A 12 35.84 -68.57 REMARK 500 2 LEU A 13 23.91 40.46 REMARK 500 2 GLU A 15 10.93 49.13 REMARK 500 2 ALA A 18 -6.95 -49.45 REMARK 500 2 THR A 43 -127.51 -144.73 REMARK 500 2 ARG A 44 79.85 56.89 REMARK 500 2 GLU A 45 -52.26 -156.27 REMARK 500 2 GLU A 62 72.17 -65.19 REMARK 500 2 ASP A 70 -21.28 73.51 REMARK 500 2 PRO A 82 168.12 -36.50 REMARK 500 2 PRO A 97 75.56 -57.48 REMARK 500 2 ASP A 98 -59.82 -177.62 REMARK 500 2 LEU A 108 -21.04 66.35 REMARK 500 2 ASP A 110 13.23 54.31 REMARK 500 REMARK 500 THIS ENTRY HAS 621 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE N-TERMINAL RESIDUES GIPEF ARE THE EXPRESSION TAG REMARK 999 FROM THE PLASMID VECTOR USED TO EXPRESS THE PROTEIN. DBREF 2K9U A 6 119 UNP Q59H94 Q59H94_HUMAN 919 1032 DBREF 2K9U B 1 24 UNP Q8WUP2 FBLI1_HUMAN 1 24 SEQADV 2K9U GLY A 1 UNP Q59H94 EXPRESSION TAG SEQADV 2K9U ILE A 2 UNP Q59H94 EXPRESSION TAG SEQADV 2K9U PRO A 3 UNP Q59H94 EXPRESSION TAG SEQADV 2K9U GLU A 4 UNP Q59H94 EXPRESSION TAG SEQADV 2K9U PHE A 5 UNP Q59H94 EXPRESSION TAG SEQRES 1 A 119 GLY ILE PRO GLU PHE PHE GLN PHE THR VAL GLY PRO LEU SEQRES 2 A 119 GLY GLU GLY GLY ALA HIS LYS VAL ARG ALA GLY GLY THR SEQRES 3 A 119 GLY LEU GLU ARG GLY VAL ALA GLY VAL PRO ALA GLU PHE SEQRES 4 A 119 SER ILE TRP THR ARG GLU ALA GLY ALA GLY GLY LEU SER SEQRES 5 A 119 ILE ALA VAL GLU GLY PRO SER LYS ALA GLU ILE ALA PHE SEQRES 6 A 119 GLU ASP ARG LYS ASP GLY SER CYS GLY VAL SER TYR VAL SEQRES 7 A 119 VAL GLN GLU PRO GLY ASP TYR GLU VAL SER ILE LYS PHE SEQRES 8 A 119 ASN ASP GLU HIS ILE PRO ASP SER PRO PHE VAL VAL PRO SEQRES 9 A 119 VAL ALA SER LEU SER ASP ASP ALA ARG ARG LEU THR VAL SEQRES 10 A 119 THR SER SEQRES 1 B 24 MET ALA SER LYS PRO GLU LYS ARG VAL ALA SER SER VAL SEQRES 2 B 24 PHE ILE THR LEU ALA PRO PRO ARG ARG ASP VAL SHEET 1 A 4 ARG A 22 GLY A 24 0 SHEET 2 A 4 PRO A 36 TRP A 42 -1 O TRP A 42 N ARG A 22 SHEET 3 A 4 SER A 72 VAL A 78 -1 O TYR A 77 N ALA A 37 SHEET 4 A 4 GLU A 62 GLU A 66 -1 N ALA A 64 O SER A 76 SHEET 1 B 5 GLY A 31 VAL A 32 0 SHEET 2 B 5 PHE A 101 ALA A 106 1 O ALA A 106 N GLY A 31 SHEET 3 B 5 GLY A 83 PHE A 91 -1 N TYR A 85 O VAL A 103 SHEET 4 B 5 GLY A 49 GLU A 56 -1 N GLU A 56 O GLU A 86 SHEET 5 B 5 ALA B 10 LEU B 17 -1 O SER B 11 N VAL A 55 CISPEP 1 SER A 99 PRO A 100 1 0.33 CISPEP 2 SER A 99 PRO A 100 2 -2.72 CISPEP 3 SER A 99 PRO A 100 3 -2.24 CISPEP 4 SER A 99 PRO A 100 4 -2.39 CISPEP 5 SER A 99 PRO A 100 5 -2.10 CISPEP 6 SER A 99 PRO A 100 6 -1.90 CISPEP 7 SER A 99 PRO A 100 7 -2.32 CISPEP 8 SER A 99 PRO A 100 8 -2.13 CISPEP 9 SER A 99 PRO A 100 9 -2.64 CISPEP 10 SER A 99 PRO A 100 10 -1.98 CISPEP 11 SER A 99 PRO A 100 11 -2.34 CISPEP 12 SER A 99 PRO A 100 12 -2.61 CISPEP 13 SER A 99 PRO A 100 13 -2.60 CISPEP 14 SER A 99 PRO A 100 14 -2.44 CISPEP 15 SER A 99 PRO A 100 15 -2.33 CISPEP 16 SER A 99 PRO A 100 16 -1.86 CISPEP 17 SER A 99 PRO A 100 17 -1.86 CISPEP 18 SER A 99 PRO A 100 18 -2.39 CISPEP 19 SER A 99 PRO A 100 19 -0.10 CISPEP 20 SER A 99 PRO A 100 20 -1.67 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000